Booz Allen Hamilton Holding Corporation (BAH) Institutional Ownership & Insider Trading

556 institutions reported holding Booz Allen Hamilton Holding Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 3 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason

BAHBooz Allen Hamilton Holding CorporationFollow BAH — free

Consulting Services · Industrials

—

Price chart with a free account

Market cap: 9.3B
P/E TTM: 12.2
Dividend yield: 3.0%
52-week: —
Next earnings: 23 Oct, in -1 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

556 institutions held 97.7% of the shares. Across filers that reported both quarters, shares held changed -1.1%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	556	116	-1.1%	173	70	189	66
Mar 26	548	115	-9.3%	142	59	225	131
Dec 25	617	127	+4.7%	178	67	250	156
Sep 25	698	119	+1.8%	205	72	260	70
Jun 25	691	118	-2.5%	219	72	257	82
Mar 25	707	119	+1.8%	262	81	237	97
Dec 24	722	119	-0.5%	231	95	219	67
Sep 24	678	114	-6.7%	217	43	224	71

Booz Allen Hamilton Holding Corporation — questions

Who owns Booz Allen Hamilton Holding Corporation stock?: 556 institutions reported Booz Allen Hamilton Holding Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (11.2%), VANGUARD PORTFOLIO MANAGEMENT LLC (6.2%), PRIMECAP MANAGEMENT CO/CA/ (5.4%).
Are Booz Allen Hamilton Holding Corporation insiders buying or selling?: 3 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Booz Allen Hamilton Holding Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.